Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 424

1.

Physical Exercise for Treatment of Mood Disorders: A Critical Review.

Hearing CM, Chang WC, Szuhany KL, Deckersbach T, Nierenberg AA, Sylvia LG.

Curr Behav Neurosci Rep. 2016 Dec;3(4):350-359. doi: 10.1007/s40473-016-0089-y. Epub 2016 Oct 14.

PMID:
28503402
2.

Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study.

Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG.

J Affect Disord. 2017 Apr 5;217:183-189. doi: 10.1016/j.jad.2017.03.070. [Epub ahead of print]

PMID:
28411507
3.

Clinical correlates of acute bipolar depressive episode with psychosis.

Caldieraro MA, Sylvia LG, Dufour S, Walsh S, Janos J, Rabideau DJ, Kamali M, McInnis MG, Bobo WV, Friedman ES, Gao K, Tohen M, Reilly-Harrington NA, Ketter TA, Calabrese JR, McElroy SL, Thase ME, Shelton RC, Bowden CL, Kocsis JH, Deckersbach T, Nierenberg AA.

J Affect Disord. 2017 Mar 30;217:29-33. doi: 10.1016/j.jad.2017.03.059. [Epub ahead of print]

PMID:
28365478
4.

Illness severity and biomarkers in depression: Using a unidimensional rating scale to examine BDNF.

Caldieraro MA, Vares EA, Souza LH, Spanemberg L, Guerra TA, Wollenhaupt-Aguiar B, Ferrari P, Nierenberg AA, Fleck MP.

Compr Psychiatry. 2017 May;75:46-52. doi: 10.1016/j.comppsych.2017.02.014. Epub 2017 Mar 6.

PMID:
28301802
5.

Poor quality of life and functioning in bipolar disorder.

Sylvia LG, Montana RE, Deckersbach T, Thase ME, Tohen M, Reilly-Harrington N, McInnis MG, Kocsis JH, Bowden C, Calabrese J, Gao K, Ketter T, Shelton RC, McElroy SL, Friedman ES, Rabideau DJ, Nierenberg AA.

Int J Bipolar Disord. 2017 Dec;5(1):10. doi: 10.1186/s40345-017-0078-4. Epub 2017 Mar 27.

6.

Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.

Köhler-Forsberg O, Sylvia L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy S, Shelton RC, Nierenberg AA.

Depress Anxiety. 2017 Mar;34(3):281-290. doi: 10.1002/da.22601. Epub 2017 Jan 30.

PMID:
28135023
7.

Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders.

Gold AK, Montana RE, Sylvia LG, Nierenberg AA, Deckersbach T.

Curr Behav Neurosci Rep. 2016 Dec;3(4):340-349. Epub 2016 Oct 6.

PMID:
27917364
8.

Predictive analytics in mental health: applications, guidelines, challenges and perspectives.

Hahn T, Nierenberg AA, Whitfield-Gabrieli S.

Mol Psychiatry. 2017 Jan;22(1):37-43. doi: 10.1038/mp.2016.201. Epub 2016 Nov 15.

PMID:
27843153
9.

L-Methylfolate For Bipolar I depressive episodes: An open trial proof-of-concept registry.

Nierenberg AA, Montana R, Kinrys G, Deckersbach T, Dufour S, Baek JH.

J Affect Disord. 2017 Jan 1;207:429-433. doi: 10.1016/j.jad.2016.09.053. Epub 2016 Oct 1.

PMID:
27794238
10.

Do Sleep Disturbances Predict or Moderate the Response to Psychotherapy in Bipolar Disorder?

Sylvia LG, Salcedo S, Peters AT, Magalhães PV, Frank E, Miklowitz DJ, Otto MW, Berk M, Nierenberg AA, Deckersbach T.

J Nerv Ment Dis. 2017 Mar;205(3):196-202. doi: 10.1097/NMD.0000000000000579.

PMID:
27660995
11.

Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.

Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA.

J Affect Disord. 2016 Nov 15;205:159-164. doi: 10.1016/j.jad.2016.07.007. Epub 2016 Jul 5.

PMID:
27449548
12.

Testing for clinical inertia in medication treatment of bipolar disorder.

Hodgkin D, Merrick EL, O'Brien PL, McGuire TG, Lee S, Deckersbach T, Nierenberg AA.

J Affect Disord. 2016 Nov 15;205:13-19. doi: 10.1016/j.jad.2016.03.073. Epub 2016 Jun 21.

PMID:
27391267
13.

Bipolar disorder: multiple pathways to neuroprogression.

Nierenberg AA.

Acta Psychiatr Scand. 2016 Aug;134(2):89-90. doi: 10.1111/acps.12617. No abstract available.

PMID:
27384497
14.

A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD.

Deckersbach T, Peters AT, Sylvia LG, Gold AK, da Silva Magalhaes PV, Henry DB, Frank E, Otto MW, Berk M, Dougherty DD, Nierenberg AA, Miklowitz DJ.

J Affect Disord. 2016 Oct;203:152-7. doi: 10.1016/j.jad.2016.03.064. Epub 2016 May 31.

PMID:
27289316
15.

Empirically supported psychosocial interventions for bipolar disorder: Current state of the research.

Salcedo S, Gold AK, Sheikh S, Marcus PH, Nierenberg AA, Deckersbach T, Sylvia LG.

J Affect Disord. 2016 Sep 1;201:203-14. doi: 10.1016/j.jad.2016.05.018. Epub 2016 May 14. Review.

PMID:
27243619
16.

The Effect of Concomitant Treatment With SSRIs and Statins: A Population-Based Study.

Köhler O, Gasse C, Petersen L, Ingstrup KG, Nierenberg AA, Mors O, Østergaard SD.

Am J Psychiatry. 2016 Aug 1;173(8):807-15. doi: 10.1176/appi.ajp.2016.15040463. Epub 2016 May 3.

PMID:
27138586
17.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11.

PMID:
27126391
18.

A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorder.

Sylvia LG, Gold AK, Stange JP, Peckham AD, Deckersbach T, Calabrese JR, Weiss RD, Perlis RH, Nierenberg AA, Ostacher MJ.

Am J Addict. 2016 Mar;25(2):94-8. doi: 10.1111/ajad.12346. Epub 2016 Feb 19.

19.

Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.

Deckersbach T, Nierenberg AA, McInnis MG, Salcedo S, Bernstein EE, Kemp DE, Shelton RC, McElroy SL, Sylvia LG, Kocsis JH, Bobo WV, Friedman ES, Singh V, Tohen M, Bowden CL, Ketter TA, Calabrese JR, Thase ME, Reilly-Harrington NA, Rabideau DJ, Kinrys G, Kamali M.

J Clin Psychiatry. 2016 Jan;77(1):100-8. doi: 10.4088/JCP.14m09210.

PMID:
26845265
20.

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for bipolar disorder.

Nierenberg AA, McElroy SL, Friedman ES, Ketter TA, Shelton RC, Deckersbach T, McInnis MG, Bowden CL, Tohen M, Kocsis JH, Calabrese JR, Kinrys G, Bobo WV, Singh V, Kamali M, Kemp D, Brody B, Reilly-Harrington NA, Sylvia LG, Shesler LW, Bernstein EE, Schoenfeld D, Rabideau DJ, Leon AC, Faraone S, Thase ME.

J Clin Psychiatry. 2016 Jan;77(1):90-9. doi: 10.4088/JCP.14m09349.

PMID:
26845264

Supplemental Content

Loading ...
Support Center